Document Detail


Risk of deep vein thrombosis following a single negative whole-leg compression ultrasound: a systematic review and meta-analysis.
MedLine Citation:
PMID:  20124539     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: In patients with suspected lower extremity deep vein thrombosis (DVT), compression ultrasound (CUS) is typically the initial test to confirm or exclude DVT. Patients with an initial negative CUS result often require repeat CUS after 5 to 7 days. Whole-leg CUS may exclude proximal and distal DVT in a single evaluation.
OBJECTIVE: To determine the risk of venous thromboembolism after withholding anticoagulation in patients with suspected lower extremity DVT following a single negative whole-leg CUS result.
DATA SOURCES: MEDLINE, EMBASE, CINAHL, LILACS, Cochrane, and Health Technology Assessments databases were searched for articles published from January 1970 through November 2009. Supplemental searches were performed of Internet resources, reference lists, and by contacting content experts.
STUDY SELECTION: Included studies were randomized controlled trials and prospective cohort studies of patients with suspected DVT and a negative whole-leg CUS result who did not receive anticoagulant therapy, and were followed up at least 90 days for venous thromboembolism events.
DATA EXTRACTION: Two authors independently reviewed and extracted data regarding a single positive or negative whole-leg CUS result, occurrence of venous thromboembolism during follow-up, and study quality.
RESULTS: Seven studies were included totaling 4731 patients with negative whole-leg CUS examinations who did not receive anticoagulation. Of these, up to 647 patients (13.7%) had active cancer and up to 725 patients (15.3%) recently underwent a major surgery. Most participants were identified from an ambulatory setting. Venous thromboembolism or suspected venous thromboembolism-related death occurred in 34 patients (0.7%), including 11 patients with distal DVT (32.4%); 7 patients with proximal DVT (20.6%); 7 patients with nonfatal pulmonary emboli (20.6%); and 9 patients (26.5%) who died, possibly related to venous thromboembolism. Using a random-effects model with inverse variance weighting, the combined venous thromboembolism event rate at 3 months was 0.57% (95% confidence interval, 0.25%-0.89%).
CONCLUSION: Withholding anticoagulation following a single negative whole-leg CUS result was associated with a low risk of venous thromboembolism during 3-month follow-up.
Authors:
Stacy A Johnson; Scott M Stevens; Scott C Woller; Erica Lake; Marco Donadini; Ji Cheng; José Labarère; James D Douketis
Related Documents :
11889719 - Heparin-induced thrombocytopenia as the cause of gluteus muscle necrosis: a case study ...
11453709 - Excluding pulmonary embolism at the bedside without diagnostic imaging: management of p...
10189449 - Clinically important pulmonary emboli: does calf vein us alter outcomes?
12685059 - Venous thromboembolism in intensive care patients.
9626819 - Heparin-induced thrombocytopenia.
3970059 - Limb loss due to transvenous endocardial pacemaker therapy.
9428249 - Value of assessment of pretest probability of deep-vein thrombosis in clinical management.
2753609 - Tolerating the countertransference: a mutative process.
25323839 - The course of myasthenia gravis with systemic lupus erythematosus.
Publication Detail:
Type:  Journal Article; Meta-Analysis; Review    
Journal Detail:
Title:  JAMA     Volume:  303     ISSN:  1538-3598     ISO Abbreviation:  JAMA     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-03     Completed Date:  2010-02-22     Revised Date:  2014-09-17    
Medline Journal Info:
Nlm Unique ID:  7501160     Medline TA:  JAMA     Country:  United States    
Other Details:
Languages:  eng     Pagination:  438-45     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anticoagulants / therapeutic use*
Cohort Studies
Female
Humans
Male
Middle Aged
Pressure
Randomized Controlled Trials as Topic
Risk
Ultrasonography / methods
Venous Thrombosis / drug therapy*,  epidemiology,  ultrasonography*
Chemical
Reg. No./Substance:
0/Anticoagulants
Comments/Corrections
Comment In:
JAMA. 2010 Feb 3;303(5):454-5   [PMID:  20124544 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Brainstem serotonergic deficiency in sudden infant death syndrome.
Next Document:  Vitamin D receptor gene, biochemical bone markers and bone mineral density in Mexican women on dialy...